Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study

J Infect. 2021 Jan;82(1):e22-e24. doi: 10.1016/j.jinf.2020.08.045. Epub 2020 Sep 1.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents / therapeutic use*
  • COVID-19 Drug Treatment*
  • Cohort Studies
  • Comorbidity
  • Critical Illness / therapy
  • Dexamethasone / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Furosemide / therapeutic use*
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Respiratory Distress Syndrome / drug therapy
  • Respiratory Distress Syndrome / prevention & control
  • Retrospective Studies
  • SARS-CoV-2 / drug effects*
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use*

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Sodium Potassium Chloride Symporter Inhibitors
  • Furosemide
  • Dexamethasone
  • Methylprednisolone